Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients -: In reply

被引:0
作者
Seeman, P
机构
[1] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A8, Canada
[2] Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A8, Canada
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:284 / 284
页数:1
相关论文
共 50 条
[21]   Dopamine D2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia [J].
Vanover, Kimberly E. ;
Davis, Robert E. ;
Zhou, Yun ;
Ye, Weiguo ;
Brasic, James R. ;
Gapasin, Lorena ;
Saillard, Jelena ;
Weingart, Michal ;
Litman, Robert E. ;
Mates, Sharon ;
Wong, Dean F. .
NEUROPSYCHOPHARMACOLOGY, 2019, 44 (03) :598-605
[22]   D2 receptor occupancy under recommended and high doses of olanzapine [J].
Harvey, EJ ;
Taylor, DM ;
Flanagan, RJ .
JOURNAL OF PSYCHOPHARMACOLOGY, 2001, 15 (03) :213-213
[23]   Comparaison between olanzapine and haloperidol on the procedural learning and on the striatal D2 receptor occupancy in schizophrenia [J].
Paquet, F ;
Soucy, J ;
Stip, E ;
Elie, A ;
Cheneval, E ;
Bédard, M .
SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) :117-118
[24]   A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian) [J].
Y. Hodé ;
M. Reimold ;
A. Demazières ;
G. Reischl ;
F. Bayle ;
P. Nuss ;
A. Hameg ;
M. Dib ;
J. P. Macher .
Psychopharmacology, 2005, 180 :377-384
[25]   A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian) [J].
Hodé, Y ;
Reimold, M ;
Demaziéres, A ;
Reischl, G ;
Bayle, F ;
Nuss, P ;
Hameg, A ;
Dib, M ;
Macher, J .
PSYCHOPHARMACOLOGY, 2005, 180 (02) :377-384
[26]   Effects of age on dopamine D2 receptor availability in striatal subdivisions: A high-resolution positron emission tomography study [J].
Kim, Jong-Hoon ;
Son, Young-Don ;
Kim, Hang-Keun ;
Lee, Sang-Yoon ;
Cho, Seo-Eun ;
Kim, Young-Bo ;
Cho, Zang-Hee .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 (12) :885-891
[27]   In vivo quantification of striatal dopamine D2 receptor occupancy by JNJ-37822681 using [11C]raclopride and positron emission tomography [J].
Beek, E. Te ;
de Boer, P. ;
Moerland, M. ;
Schmidt, M. ;
Hoetjes, N. ;
Windhorst, A. ;
van Berckel, B. ;
Cohen, A. ;
van Gerven, J. M. A. ;
Lammertsma, A. .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 :107-108
[28]   In vivo quantification of striatal dopamine D2 receptor occupancy by JNJ-37822681 using [11C]raclopride and positron emission tomography [J].
te Beek, Erik T. ;
de Boer, Peter ;
Moerland, Matthijs ;
Schmidt, Mark E. ;
Hoetjes, Nikie J. ;
Windhorst, Albert D. ;
van Berckel, Bart N. M. ;
Cohen, Adam F. ;
van Gerven, Joop M. A. ;
Lammertsma, Adriaan A. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (08) :1128-1135
[29]   Cerebral D2 and 5-HT2 receptor occupancy in schizophrenic patients treated with olanzapine or clozapine [J].
Moresco, RM ;
Cavallaro, R ;
Messa, C ;
Bravi, D ;
Gobbo, C ;
Galli, L ;
Lucignani, G ;
Colombo, C ;
Rizzo, G ;
Velonà, I ;
Smeraldi, E ;
Fazio, F .
JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (03) :355-365
[30]   Determination of dopamine D2 receptor occupancy by lurasidone using positron emission tomography in healthy male subjects [J].
Wong, Dean F. ;
Kuwabara, Hiroto ;
Brasic, James Robert ;
Stock, Thomas ;
Maini, Atul ;
Gean, Emily G. ;
Loebel, Antony .
PSYCHOPHARMACOLOGY, 2013, 229 (02) :245-252